Deficits in BDNF signaling are associated with the pathogenesis of various neurological and psychiatric disorders, including Alzheimer’s disease (AD) and depression [20,21,22], whereas BDNF administration attenuates amyloid-β peptide-induced memory deficits [23]. The gene discussed is BDNF; the disease is depressive symptom measurement.